Neutrophils as immune effector cells in antibody therapy in cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neutrophils as immune effector cells in antibody therapy in cancer

Published:2022-11-04 Issue:1 Volume:314 Page:280-301
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:Immunological Reviews

Author:

Behrens Leonie M.¹²³,van Egmond Marjolein¹²³⁴,van den Berg Timo K.⁵

Affiliation:

1. Department of Molecular Cell Biology and Immunology, Amsterdam UMC Vrije Universiteit Amsterdam HV Amsterdam The Netherlands

2. Cancer Center Amsterdam, Cancer Biology and Immunology HV Amsterdam The Netherlands

3. Amsterdam institute for Infection and Immunity, Cancer Immunology HV Amsterdam The Netherlands

4. Department of Surgery, Amsterdam UMC Vrije Universiteit Amsterdam HV Amsterdam The Netherlands

5. Byondis B.V. CM Nijmegen The Netherlands

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imr.13159

Reference244 articles.

1. Cancer Immunotherapy

2. Cancer immunoediting: from immunosurveillance to tumor escape

3. Immune checkpoint signaling and cancer immunotherapy

4. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I

5. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR-targeting oxygen-saturated nanophotosensitizers for orchestrating multifaceted antitumor responses by counteracting immunosuppressive milieu;Journal of Controlled Release;2024-11

2. Mechanistic insights into the nutritional and therapeutic potential of Spirulina (Arthrospira) spp.: Challenges and opportunities;Trends in Food Science & Technology;2024-09

3. STING-Activating Polymer–Drug Conjugates for Cancer Immunotherapy;ACS Central Science;2024-08-19

4. Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment;Annual Review of Chemical and Biomolecular Engineering;2024-07-24

5. Antibody-drug conjugate adverse effects can be understood and addressed based on immune complex clearance mechanisms;Blood;2024-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3